Liquid biopsy to diagnose EGFR T790M mutation in previously radiated non-small-cell lung cancer brain metastases and rapid response to osimertinib

被引：0
|
作者：
Matzdorff, A. [1 ]
Meier, A. [1 ]
Lenze, D. [2 ]
Hartmann, J. [3 ]
Pielsticker, C. [3 ]
Gawliczek, A. [1 ]
机构：
[1] Asklepios Klinikum Uckermark, Med Klin 2, Schwedt, Germany
[2] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany
[3] Asklepios Klinikum Uckermark, Inst Radiol, Schwedt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P815
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [41] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
    Prim, Nathalie
    Quoix, Elisabeth
    Beau-Faller, Michele
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
  • [42] The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis
    Guo, Liuxian
    Zhou, Guojin
    Huang, Min
    Tang, Kejing
    Xu, Jing
    Chen, Jie
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (04):
  • [43] Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation
    Dogan, I.
    Gurbuz, M.
    Paksoy, N.
    Khanmamadov, N.
    Vatansever, S.
    Saip, P.
    Demirkazik, A.
    Aydiner, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1351 - S1351
  • [44] Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation Two Case Reports
    Koba, Taro
    Kijima, Takashi
    Takimoto, Takayuki
    Hirata, Haruhiko
    Naito, Yujiro
    Hamaguchi, Masanari
    Otsuka, Tomoyuki
    Kuroyama, Muneyoshi
    Nagatomo, Izumi
    Takeda, Yoshito
    Kida, Hiroshi
    Kumanogoh, Atsushi
    MEDICINE, 2017, 96 (06)
  • [45] ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation
    Karachaliou, Niki
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Viteri, Santiago
    Moran, Teresa
    Carcereny, Enric
    Massuti, Bartomeu
    Vergnenegre, Alain
    de Marinis, Filippo
    Angel Molina, Miguel
    Teixido, Cristina
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (03) : 122 - 130
  • [46] Does T790M Disappear? Successful Gefitinib Rechallenge After T790M Disappearance in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Kaji, Reiko
    Fujita, Shiro
    Imai, Yukihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E27 - E29
  • [47] Genomic Profiling of EGFR T790M Mutated Non-Small Cell Lung Cancer to Evaluate the Mechanisms of Resistance to Osimertinib
    Puri, S.
    Hicks, J.
    Knepper, T.
    Smith, M.
    Boyle, T.
    Gray, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1848 - S1849
  • [48] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [49] Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
    Auliac, Jean Bernard
    Perol, Maurice
    Planchard, David
    Monnet, Isabelle
    Wislez, Marie
    Doubre, Helene
    Guisier, Florian
    Pichon, Eric
    Greillier, Laurent
    Mastroianni, Benedicte
    Decroisette, Chantal
    Schott, Roland
    Le Moulec, Sylvestre
    Arrondeau, Jennifer
    Cortot, Alexis B.
    Geriniere, Laurence
    Renault, Aldo
    Daniel, Catherine
    Falchero, Lionel
    Chouaid, Christos
    LUNG CANCER, 2019, 127 : 96 - 102
  • [50] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
12345